News coverage about K2M Group (NASDAQ:KTWO) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. K2M Group earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the medical device company an impact score of 45.2602973418737 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Several equities research analysts recently commented on KTWO shares. Zacks Investment Research upgraded shares of K2M Group from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Wednesday, October 4th. Piper Jaffray Companies restated a “buy” rating and issued a $28.00 price target on shares of K2M Group in a research report on Thursday, September 28th. Royal Bank of Canada restated a “buy” rating and issued a $26.00 price target on shares of K2M Group in a research report on Friday, September 22nd. Cowen set a $28.00 price target on shares of K2M Group and gave the company a “buy” rating in a research report on Thursday, August 17th. Finally, Oppenheimer set a $24.00 price target on shares of K2M Group and gave the company a “buy” rating in a research report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the company. K2M Group currently has an average rating of “Buy” and a consensus target price of $24.40.

Shares of K2M Group (KTWO) opened at $17.36 on Wednesday. K2M Group has a 12-month low of $16.44 and a 12-month high of $25.99. The company has a debt-to-equity ratio of 0.29, a current ratio of 3.06 and a quick ratio of 1.67.

K2M Group (NASDAQ:KTWO) last released its earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01). K2M Group had a negative return on equity of 16.02% and a negative net margin of 16.22%. The company had revenue of $62.65 million during the quarter, compared to analysts’ expectations of $62.69 million. During the same quarter in the previous year, the company earned ($0.19) EPS. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. equities research analysts expect that K2M Group will post -0.86 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact K2M Group (KTWO) Share Price” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-k2m-group-ktwo-share-price/1760954.html.

About K2M Group

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Insider Buying and Selling by Quarter for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.